Iron is included in the structure of a number of important proteins. First of all, hemoglobin, which, thanks to iron, transports oxygen from the lungs to all tissues, organs and cells. Having given up oxygen, hemoglobin removes carbon dioxide from the body. Thus, red blood cells containing hemoglobin molecules supply cells with oxygen and take away carbon dioxide. Buying Ferlixit and using it is very useful.

Iron not only provides organs and cells with oxygen, but at the same time protects them from the damaging effects of highly toxic peroxide compounds formed in oxidative processes, primarily hydrogen peroxide produced, in particular, by white blood cells - leukocytes.

Contraindications: Hypersensitivity, anemia are not associated with Fe deficiency, hyperchromatosis, pregnancy (first trimester). Use with caution in case of liver failure, acute infectious diseases, bronchial asthma, eczema, polyvalent allergies.

Side effects with intravenous administration:

Less than 1%: transient taste disturbances (especially a “metallic” taste in the mouth), headache, nausea, vomiting, symptoms accompanying a pronounced decrease in blood pressure. Rarely: increased body temperature, paresthesia, abdominal pain, myalgia, rash, swelling of the extremities, reactions at the injection site. Extremely rare: impaired consciousness, angioedema; anaphylactoid and allergic reactions.

Overdose with intravenous use:

Decreased blood pressure (signs of collapse are detected within 30 minutes), symptoms of hemosiderosis. Treatment: symptomatic, if necessary – Fe-binding drugs (chelates) – deferoxamine intravenously slowly, for children – 15 mg/hour, for adults – 5 mg/kg/hour (up to 80 mg/kg/day); for mild poisoning intramuscularly, for children - 1 g every 4-6 hours, for adults - 50 mg/kg (up to 4 g/day).

Dosage and method of application:

The drug is not intended for intramuscular use!

Oral use: adults - 2 ampoules per day, children - 1 ampoule per day.

On the recommendation of a doctor, the dose may be increased.

It is recommended to eat it after dissolving it in a small amount of a carbohydrate drink.

Intravenous use:

IV intravenous drip and by injection into the venous section of the dialysis system. Not intended for intramuscular administration. It is unacceptable to administer the full therapeutic dose of the drug at once. Before opening the ampoule, it is necessary to inspect the presence of sediment and damage; only a brown transparent solution can be used. The drug, diluted with a 0.9% NaCl solution, should be used within 12 hours when stored at a temperature of 4 to 25 C in daylight. Before starting treatment, it is necessary to administer a test dose in the same way as it is intended to be used during treatment: (1-2.5 ml = 20-50 mg Fe) for adults and children weighing more than 14 kg and half the daily dose (1.5 mg Fe/kg) children weighing less than 14 kg. If no adverse events develop within at least 15 minutes of observation, the remainder of the treatment dose can be administered. Drip administration: it is better to administer by drip infusion in order to reduce the risk of a pronounced decrease in blood pressure and the risk of the solution entering the perivenous space. Immediately before infusion, the drug should be diluted with a 0.9% NaCl solution in a ratio of 1:20 (for example, 1 ml - 20 mg Fe in 20 ml of a 0.9% NaCl solution). The resulting solution is administered at the following speed: 100 ml - at least 15 minutes; 200 ml – within 30 minutes; 300 ml – within 1.5 hours; 400 ml – within 2.5 hours; 500 ml – within 3.5 hours. Flow administration: it is also possible to administer it as an undiluted solution slowly intravenously at a rate of no more than 1 ml/min (20 mg Fe/min). The maximum volume of the drug should not exceed 10 ml. After administration, the patient is advised to temporarily fix his arm in an extended position. Introduction into the dialysis system: it is possible to administer directly into the venous portion of the dialysis system, strictly following the rules described for intravenous injection.

Recommended dose calculation: The dose is calculated individually in accordance with the general Fe deficiency in the body using the formula: General Fe deficiency (mg) = body weight (kg) x (normal Hb – patient’s Hb (g/l) x 0.24 + deposited Fe (mg) For patients with a body weight of less than 35 kg and a normal Hb value = 130 g/l, the amount of deposited Fe = 15 mg/kg body weight For patients with a body weight of more than 35 kg and a normal Hb value = 150 g/l, the amount of deposited Fe = 500 mg Coefficient 0.24 = 0.0034 x 0.07 x 1000 (Fe concentration in Hb - 0.34%; blood volume - 7% of body weight; coefficient 1000 - conversion of g to mg) In the case where the total therapeutic dose exceeds the maximum permissible single dose, small amounts of the drug .


If necessary, it can be prescribed simultaneously with oral Fe-containing drugs, but not earlier than 5 days after the last injection. Pharmaceutically compatible only with 0.9% NaCl solution.

Recommended in sports during increased physical activity in mid-mountain conditions, during the rehabilitation period after injuries, operations, etc. diseases.

Ferlixit 62,5 mg/5 ml ampoules

  • Product Code: Ferlixit 62,5 mg/5 ml ampoules
  • Availability: In Stock
  • $49.00

  • Ex Tax: $49.00